Clinical Trials · NCT00456300
Role of Exenatide in Type 1 Diabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Montefiore Medical Center
- Enrollment
- 11
- Start date
- Mar 2007
- Locations
- 1 site, United States
- Primary endpoint
- Mean Plasma Glucose Area Under the Curve (AUC) for Blood Glucose Concentration in the Exenatide 1.25 mcg or Exenatide 2.5 mcg Treated Groups Along With Insulin, Compared to Insulin Alone